J. Thistlethwaite to Costs and Cost Analysis
This is a "connection" page, showing publications J. Thistlethwaite has written about Costs and Cost Analysis.
Connection Strength
0.081
-
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. Transplant Proc. 1997 Feb-Mar; 29(1-2):1549.
Score: 0.033
-
OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95.
Score: 0.032
-
Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Hum Immunol. 1985 Nov; 14(3):314-23.
Score: 0.015